Target intelligence / Profile preview

Major Histocompatibility Complex Class I Antigen Presentation Pathway (MHC Class I Pathway)

Target
MHC Class I Pathway
Molecular classification
Signaling Pathway, Immune Pathway
01

Overview

The major histocompatibility complex (MHC) class I antigen presentation pathway is a fundamental component of the adaptive immune system. Its primary function is to present peptide fragments derived from intracellular proteins on the surface of all nucleated cells, allowing cytotoxic CD8+ T cells to monitor and eliminate infected or abnormal cells. The pathway involves protein degradation by the proteasome, peptide transport into the ER by TAP, peptide loading onto MHC class I molecules with the help of chaperones, and surface expression for T cell recognition. This pathway underpins cellular immunity against viruses and some intracellular bacteria while also playing roles in tumor surveillance and autoimmunity when dysregulated.

Other names
MHC-I Antigen Presentation PathwayClass I Antigen Processing PathwayHLA Class I Pathway
02

Biological functions

Antigen PresentationImmune ResponseT cell ActivationCellular ImmunityInnate Immunity Modulation
03

Disease associations

Viral InfectionCancerAutoimmunityImmunodeficiency
04

Safety considerations

Off-target effects on immune responsesPotential for autoimmunity if dysregulatedRisk of cytokine storm in certain contexts

Beyond the preview

Go deeper on Major Histocompatibility Complex Class I Antigen Presentation Pathway (MHC Class I Pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major Histocompatibility Complex Class I Antigen Presentation Pathway (MHC Class I Pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call